Large gap with delayed quotes
|
Last quote
03/17/2025 -
21:15:00
|
Bid
03/17/2025 -
20:59:59
|
Bid Volume |
Ask
03/17/2025 -
20:59:59
|
Ask Volume |
|---|---|---|---|---|
|
430.59
+9.65
(
+2.29% )
|
430.57
|
6,100 |
430.87
|
1,500 |
Analysis date: 14.03.2025
Global Evaluation
Positive
Positive
The stock is classified in the positive zone since 25.02.2025.
Interest
Very strong
Very strong
Four stars since 14.03.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 14.03.2025 at a price of 420.94.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Positive
Positive
The forty day technical trend is positive since 25.02.2025.
4wk Rel Perf
16.31%
16.31%
The four-week dividend-adjusted overperformance versus SP500 is 16.31%.
Sensibility
Low
Low
The stock has been on the low-sensitivity level since 11.02.2025.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.94%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.29%.
Mkt Cap in $bn
95.70
95.70
With a market capitalization >$8bn, ELEVANCE HEALTH is considered a large-cap stock.
G/PE Ratio
1.27
1.27
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
9.58
9.58
The estimated PE is for the year 2027.
LT Growth
10.52%
10.52%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
16
16
Over the last seven weeks, an average of 16 analysts provided earnings per share estimates.
Dividend Yield
1.64%
1.64%
The twelve month estimated dividend yield represents 15.72% of earnings forecasts.
Beta
14
14
For 1% of index variation, the stock varies on average by 0.14%.
Correlation
0.08
0.08
Stock movements are totally independent of index variations.
Value at Risk
47.97
47.97
The value at risk is estimated at USD 47.97. The risk is therefore 11.39%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
31.03.2004
31.03.2004